midazolam has been researched along with Cachexia in 1 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
Cachexia: General ill health, malnutrition, and weight loss, usually associated with chronic disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Accordingly, the bioavailability of midazolam was increased by about 3 times, thus enhancing its pharmacological effect." | 1.62 | Involvement of the Parathyroid Hormone-Related Protein on Changes in the CYP3A Expression in Cancer Cachexia. ( Chikamatsu, M; Fujita, I; Ichimizu, S; Ikegami, K; Imafuku, T; Kobayashi, K; Maeda, H; Maruyama, T; Tanaka, R; Watanabe, H; Yamada, K, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, I | 1 |
| Watanabe, H | 1 |
| Ikegami, K | 1 |
| Imafuku, T | 1 |
| Ichimizu, S | 1 |
| Chikamatsu, M | 1 |
| Kobayashi, K | 1 |
| Tanaka, R | 1 |
| Yamada, K | 1 |
| Maeda, H | 1 |
| Maruyama, T | 1 |
1 other study available for midazolam and Cachexia
| Article | Year |
|---|---|
Involvement of the Parathyroid Hormone-Related Protein on Changes in the CYP3A Expression in Cancer Cachexia.
Topics: Animals; Cachexia; Caco-2 Cells; Cytochrome P-450 CYP3A; Hep G2 Cells; Humans; Liver; Male; Midazola | 2021 |